Title : Levistolide A synergistically enhances doxorubicin‑induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway.

Pub. Date : 2019 Feb

PMID : 30483812






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Levistolide A synergistically enhances doxorubicin-induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway. Doxorubicin ATP binding cassette subfamily B member 1 Homo sapiens
2 Furthermore, multidrug resistance protein 1 (MDR1) expression in k562/dox cells was downregulated by levistolide A in a dose-dependent manner, thus suggesting that levistolide A may modulate MDR1 during cancer therapy. Doxorubicin ATP binding cassette subfamily B member 1 Homo sapiens
3 Furthermore, multidrug resistance protein 1 (MDR1) expression in k562/dox cells was downregulated by levistolide A in a dose-dependent manner, thus suggesting that levistolide A may modulate MDR1 during cancer therapy. Doxorubicin ATP binding cassette subfamily B member 1 Homo sapiens
4 Furthermore, multidrug resistance protein 1 (MDR1) expression in k562/dox cells was downregulated by levistolide A in a dose-dependent manner, thus suggesting that levistolide A may modulate MDR1 during cancer therapy. Doxorubicin ATP binding cassette subfamily B member 1 Homo sapiens